Traumatic Brain Injury: Oxidative Stress and Novel Anti-Oxidants Such as Mitoquinone and Edaravone
- PMID: 33019512
- PMCID: PMC7601591
- DOI: 10.3390/antiox9100943
Traumatic Brain Injury: Oxidative Stress and Novel Anti-Oxidants Such as Mitoquinone and Edaravone
Abstract
Traumatic brain injury (TBI) is a major health concern worldwide and is classified based on severity into mild, moderate, and severe. The mechanical injury in TBI leads to a metabolic and ionic imbalance, which eventually leads to excessive production of reactive oxygen species (ROS) and a state of oxidative stress. To date, no drug has been approved by the food and drug administration (FDA) for the treatment of TBI. Nevertheless, it is thought that targeting the pathology mechanisms would alleviate the consequences of TBI. For that purpose, antioxidants have been considered as treatment options in TBI and were shown to have a neuroprotective effect. In this review, we will discuss oxidative stress in TBI, the history of antioxidant utilization in the treatment of TBI, and we will focus on two novel antioxidants, mitoquinone (MitoQ) and edaravone. MitoQ can cross the blood brain barrier and cellular membranes to accumulate in the mitochondria and is thought to activate the Nrf2/ARE pathway leading to an increase in the expression of antioxidant enzymes. Edaravone is a free radical scavenger that leads to the mitigation of damage resulting from oxidative stress with a possible association to the activation of the Nrf2/ARE pathway as well.
Keywords: anti-oxidants; edaravone; mitoquinone; oxidative stress; traumatic brain injury.
Conflict of interest statement
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Figures



Similar articles
-
Mitoquinone supplementation alleviates oxidative stress and pathologic outcomes following repetitive mild traumatic brain injury at a chronic time point.Exp Neurol. 2022 May;351:113987. doi: 10.1016/j.expneurol.2022.113987. Epub 2022 Jan 19. Exp Neurol. 2022. PMID: 35065054
-
Mitochondrial-targeted antioxidant MitoQ provides neuroprotection and reduces neuronal apoptosis in experimental traumatic brain injury possibly via the Nrf2-ARE pathway.Am J Transl Res. 2018 Jun 15;10(6):1887-1899. eCollection 2018. Am J Transl Res. 2018. PMID: 30018728 Free PMC article.
-
Attenuation of axonal injury and oxidative stress by edaravone protects against cognitive impairments after traumatic brain injury.Brain Res. 2013 Jan 15;1490:184-92. doi: 10.1016/j.brainres.2012.09.011. Epub 2012 Sep 13. Brain Res. 2013. PMID: 22982593
-
Drug Repurposing: Promises of Edaravone Target Drug in Traumatic Brain Injury.Curr Med Chem. 2021;28(12):2369-2391. doi: 10.2174/0929867327666200812221022. Curr Med Chem. 2021. PMID: 32787753 Review.
-
Oxidative Stress in Traumatic Brain Injury.Int J Mol Sci. 2022 Oct 27;23(21):13000. doi: 10.3390/ijms232113000. Int J Mol Sci. 2022. PMID: 36361792 Free PMC article. Review.
Cited by
-
Efficacy and safety of compound porcine cerebroside and ganglioside injection (CPCGI) versus piracetam on cognition and functional outcomes for adults with traumatic brain injury: A study protocol for randomized controlled trial.Heliyon. 2024 Aug 31;10(17):e37296. doi: 10.1016/j.heliyon.2024.e37296. eCollection 2024 Sep 15. Heliyon. 2024. PMID: 39319135 Free PMC article.
-
Understanding the Molecular Progression of Chronic Traumatic Encephalopathy in Traumatic Brain Injury, Aging and Neurodegenerative Disease.Int J Mol Sci. 2023 Jan 17;24(3):1847. doi: 10.3390/ijms24031847. Int J Mol Sci. 2023. PMID: 36768171 Free PMC article. Review.
-
Molecular mechanisms underlying cyclophosphamide-induced cognitive impairment and strategies for neuroprotection in preclinical models.Mol Cell Biochem. 2024 Aug;479(8):1873-1893. doi: 10.1007/s11010-023-04805-0. Epub 2023 Jul 31. Mol Cell Biochem. 2024. PMID: 37522975 Free PMC article. Review.
-
Traumatic Brain Injury Alters Cerebral Concentrations and Redox States of Coenzymes Q9 and Q10 in the Rat.Antioxidants (Basel). 2023 Apr 23;12(5):985. doi: 10.3390/antiox12050985. Antioxidants (Basel). 2023. PMID: 37237851 Free PMC article.
-
Neuroinflammation and iron metabolism after intracerebral hemorrhage: a glial cell perspective.Front Neurol. 2025 Jan 15;15:1510039. doi: 10.3389/fneur.2024.1510039. eCollection 2024. Front Neurol. 2025. PMID: 39882361 Free PMC article. Review.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources